Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Siemens Healthcare introduces ultrasound system for rapid imaging in an emergency setting

Siemens Healthcare has launched its new portable and compact ACUSON P500TM ultrasound system, FROSK edition, enabling rapid imaging even in difficult scanning conditions. The hand-held technology can be easily carried and positioned in a range of clinical environments and is ready to image in less than 30 seconds, making it ideal for emergency settings. The system introduces two new advanced technologies that ensure sharp ultrasound images, regardless of patient and probe motion. 

SCCT statement on the PROMISE clinical trial ("A Randomized Comparison of Anatomic versus Functional Diagnostic Testing Strategies in Symptomatic Patients with Suspected Coronary Artery Disease"), presented at the ACC Scientific Sessions

Today at the American College of Cardiology (ACC) Annual Scientific Sessions in San Diego, results from the keenly anticipated PROMISE clinical trial confirmed what many cardiologists and radiologists have long suspected to be true: coronary computed tomographic angiography (coronary CTA) is extraordinarily effective in accurately diagnosing patients with low to moderate chest pain.  In most cases, coronary CTA is at least as effective as diagnostic methods such as stress tests such as SPECT myocardial perfusion imaging. 

Agfa HealthCare enhances Enterprise Imaging Suite with launch of integrated ECG Management System at ACC.15

Agfa HealthCare announced today the commercial launch of a new version of HeartStation ECG Management System featuring improved workflow capabilities that facilitate access and sharing of ECGs across the hospital enterprise. The solution will be on display at the American College of Cardiology (ACC) 2015 Scientific Session & Expo, March 14-16, 2015 in San Diego, CA.

AliveCor launches new app that automatically tells patients when their ECG recording is normal

AliveCor, Inc. announced today the launch of the latest version of the AliveECG app, with two new FDA-cleared and CE-marked automated detectors that allow patients and physicians to focus on the ECGs that matter most. The new mobile app instantly detects when an ECG is either Normal or unreadable.

Safer interventional procedures with enhancements to Toshiba’s Dose Tracking System

Measuring peak radiation skin dose during interventional procedures became a reality with Toshiba America Medical Systems, Inc.’s introduction of Dose Tracking System (DTS), which helps make exams safer for patients. To expand clinical applications, Toshiba is introducing enhancements to DTS for the entire Infinix product line, including the Elite, Select and Essential cardiovascular X-ray systems.

Prairie Heart Institute breaks a record: First cath lab in Illinois to achieve ACE accreditation

The Prairie Heart Institute at St. John's Hospital in Springfield, Illinois, has become the first cardiac catheterization laboratory in Illinois to achieve ACE accreditation. It is also one of the highest volume facilities to achieve this notable accomplishment.

SCAI 2015 Hildner Lecture Will Highlight Critical Need for More Clinical Research in Interventional Cardiology

New clinical research is essential to the development of hospital quality measurement, public reporting and pay-for-performance programs, according to Robert Harrington, MD, FSCAI, chair of the Department of Medicine at Stanford University School of Medicine, who will present the Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions Hildner Lecture, "The Future of Clinical Research in Interventional Cardiology: Challenges and Opportunities," on Friday, May 8, in San Diego.

Infraredx announces research collaboration with Massachusetts General Hospital to explore new generation of cardiovascular imaging devices

BURLINGTON, Mass. – December 16, 2014 – Infraredx, Inc., a cardiovascular imaging company pioneering the personalized diagnosis of coronary artery disease, today announced a collaboration with Massachusetts General Hospital (MGH) and leading coronary imaging researcher, Gary Tearney, M.D., Ph.D., professor of pathology at Harvard Medical School, Mike and Sue Hazard Family MGH Research Scholar, and founder of the Tearney Lab at the Wellman Center for Photomedicine at MGH. 

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup